Journal article icon

Journal article

EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2016 update

Abstract:

Recent insights in RA necessitated updating the EULAR RA management recommendations. A large international Task Force based decisions on evidence from 3 systematic literature reviews, developing 4 overarching principles and 12 recommendations (versus 3 and 14, respectively, in 2013). The recommendations address conventional synthetic (cs) DMARDs (methotrexate [MTX], leflunomide, sulfasalazine); glucocorticoids (GC); biological (b) DMARDs (TNF-inhibitors [adalimumab, certolizumab pegol, eta...

Expand abstract
Publication status:
Published
Peer review status:
Peer reviewed
Version:
Accepted manuscript

Actions


Access Document


Files:
Publisher copy:
10.1136/annrheumdis-2016-210715

Authors


Smolen, JS More by this author
Landewé, R More by this author
Bijlsma, J More by this author
Burmester, G More by this author
Chatzidionysiou, K More by this author
Expand authors...
European League Against Rheumatism More from this funder
Publisher:
BMJ Publishing Group Publisher's website
Journal:
Annals of the Rheumatic Diseases Journal website
Volume:
76
Issue:
6
Pages:
960-977
Publication date:
2017-03-06
Acceptance date:
2017-02-09
DOI:
EISSN:
1468-2060
ISSN:
0003-4967
Pubs id:
pubs:727898
URN:
uri:5f918412-6760-4896-805a-cd97ba4e85b7
UUID:
uuid:5f918412-6760-4896-805a-cd97ba4e85b7
Local pid:
pubs:727898

Terms of use


Metrics



If you are the owner of this record, you can report an update to it here: Report update to this record

TO TOP